{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:43:33Z","timestamp":1793922213704,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cyto.2019.154892","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T20:48:28Z","timestamp":1572986908000},"page":"154892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["A systematic review on the functional role of Th1\/Th2 cytokines in type 2 diabetes and related metabolic complications"],"prefix":"10.1016","volume":"126","author":[{"given":"Thabsile","family":"Mahlangu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiwayinkosi V.","family":"Dludla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawanda M.","family":"Nyambuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuyolwethu","family":"Mxinwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithandiwe E.","family":"Mazibuko-Mbeje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marcheggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani B.","family":"Nkambule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.154892_b0005","unstructured":"World Health Organization, Noncommunicable diseases. Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases. Accessed 20 April 2019."},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5483\/BMBRep.2016.49.3.268","article-title":"The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities","volume":"49","author":"Erion","year":"2016","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Martin-Timon","year":"2014","journal-title":"World J. Diabetes"},{"issue":"9","key":"10.1016\/j.cyto.2019.154892_b0020","doi-asserted-by":"crossref","first-page":"e23999","DOI":"10.1371\/journal.pone.0023999","article-title":"Type 2 diabetes is associated with altered NF-kappaB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS","volume":"6","author":"Andreasen","year":"2011","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.cyto.2019.154892_b0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.cyto.2019.154892_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2019.154892_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plipres.2018.04.002","article-title":"STAT3: The art of multi-tasking of metabolic and immune functions in obesity","volume":"70","author":"Hu","year":"2018","journal-title":"Progr. Lipid Res."},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0040","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/s41598-017-07230-8","article-title":"Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications","volume":"7","author":"Gupta","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/dxw006","article-title":"CD4+ T-cell subsets in inflammatory diseases: beyond the Th1\/Th2 paradigm","volume":"28","author":"Hirahara","year":"2016","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0050","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1380-2933(97)10005-7","article-title":"The TH1\/TH2 paradigm in allergy","volume":"3","author":"Maggi","year":"1998","journal-title":"Immunotechnol.: Int. J. Immunol. Eng."},{"issue":"9","key":"10.1016\/j.cyto.2019.154892_b0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/154405910808700908","article-title":"A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1\/Th2 paradigm in the context of Th17 cells and IL-17","volume":"87","author":"Gaffen","year":"2008","journal-title":"J. Dental Res."},{"key":"10.1016\/j.cyto.2019.154892_b0065","doi-asserted-by":"crossref","first-page":"7457269","DOI":"10.1155\/2018\/7457269","article-title":"Role of adaptive and innate immunity in type 2 diabetes mellitus","volume":"2018","author":"Zhou","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cyto.2019.154892_b0070","doi-asserted-by":"crossref","first-page":"6494795","DOI":"10.1155\/2017\/6494795","article-title":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation","volume":"2017","author":"Xia","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/2230-8210.180002","article-title":"Th1\/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender","volume":"20","author":"Vaseghi","year":"2016","journal-title":"Indian J. Endocrinol. Metabol."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2019.154892_b0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cyto.2006.04.012","article-title":"TH1\/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma","volume":"34","author":"Rachmiel","year":"2006","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cei.12672","article-title":"CD4 T cell differentiation in type 1 diabetes","volume":"183","author":"Walker","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13643-018-0835-1","article-title":"T cell activation and cardiovascular risk in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis","volume":"7","author":"Nyambuya","year":"2018","journal-title":"Syst. Rev."},{"issue":"2019","key":"10.1016\/j.cyto.2019.154892_b0095","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.metop.2019.100015","article-title":"Obesity-induced inflammation and insulin resistance: A mini-review on T-cells","volume":"3","author":"Nyambuya","year":"2019","journal-title":"Metabol. Open"},{"key":"10.1016\/j.cyto.2019.154892_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.cyto.2019.154892_b0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J. Epidemiol. Commun. Health"},{"issue":"6","key":"10.1016\/j.cyto.2019.154892_b0110","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000131105","article-title":"Relationship between diabetic macular edema and peripheral Th1\/Th2 balance, Ophthalmologica","volume":"222","author":"Itoi","year":"2008","journal-title":"J. Int. d'ophtalmologie. Int. J. Ophthalmol. Zeitschrift fur Augenheilkunde"},{"issue":"9","key":"10.1016\/j.cyto.2019.154892_b0120","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.metabol.2015.04.005","article-title":"Low blood and vitreal BDNF, LXA4 and altered Th1\/Th2 cytokine balance are potential risk factors for diabetic retinopathy","volume":"64","author":"Kaviarasan","year":"2015","journal-title":"Metabol.: Clin. Exp."},{"key":"10.1016\/j.cyto.2019.154892_b0125","first-page":"2931","article-title":"Changes to tear cytokines of type 2 diabetic patients with or without retinopathy","volume":"16","author":"Liu","year":"2010","journal-title":"Mol. Vision"},{"key":"10.1016\/j.cyto.2019.154892_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2016.12.040","article-title":"Sitagliptin inhibit human lymphocytes proliferation and Th1\/Th17 differentiation in vitro, European journal of pharmaceutical sciences : official journal of the European Federation for","volume":"100","author":"Pinheiro","year":"2017","journal-title":"Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2019.154892_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1164\/rccm.201409-1587OC","article-title":"Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma","volume":"191","author":"Rastogi","year":"2015","journal-title":"Am. J. Respirat. Crit. Care Med."},{"key":"10.1016\/j.cyto.2019.154892_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0145","article-title":"Relationship of IL-5 with Th1 and Th2 cytokines in individuals with or without type-2 diabetes","volume":"5","author":"Ahmad","year":"2015","journal-title":"J. Glycom. Lipidomics"},{"key":"10.1016\/j.cyto.2019.154892_b0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2017.08.012","article-title":"Subtyping of type 1 diabetes as classified by anti-GAD antibody, IgE levels, and tyrosine kinase 2 (TYK2) promoter variant in the Japanese","volume":"23","author":"Mine","year":"2017","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0155","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15037311","article-title":"Th1\/Th2 cytokine expression in diabetic retinopathy","volume":"15","author":"Cao","year":"2016","journal-title":"Genet. Mol. Res.: GMR"},{"key":"10.1016\/j.cyto.2019.154892_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diabres.2019.02.007","article-title":"The effect of short-term intensive insulin therapy on circulating T cell subpopulations in patients with newly diagnosed type 2 diabetes mellitus","volume":"149","author":"Cheng","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.cyto.2019.154892_b0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.cyto.2019.154892_b0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJR.0b013e3282efaf50","article-title":"The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus","volume":"14","author":"Kadoglou","year":"2007","journal-title":"Eur. J. Cardiovascular Prevent. Rehabil.: Off. J. Eur. Soc. Cardiol., Working Groups Epidemiol. Prevent. Cardiac Rehabil. Exercise Physiol."},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4314\/ahs.v16i3.11","article-title":"Modulation of immune cells and Th1\/Th2 cytokines in insulin-treated type 2 diabetes mellitus","volume":"16","author":"Nekoua","year":"2016","journal-title":"African Health Sci."},{"issue":"10","key":"10.1016\/j.cyto.2019.154892_b0180","doi-asserted-by":"crossref","first-page":"e0139962","DOI":"10.1371\/journal.pone.0139962","article-title":"Associations of circulating lymphocyte subpopulations with type 2 diabetes: Cross-Sectional Results from the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"10","author":"Olson","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0185","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1038\/s41598-018-22913-6","article-title":"Association of NF-E2 related factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus","volume":"8","author":"Sireesh","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cyto.2019.154892_b0190","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bjsm.2007.043562","article-title":"Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production","volume":"43","author":"Yeh","year":"2009","journal-title":"Brit. J. Sports Med."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum. Immunol."},{"issue":"15","key":"10.1016\/j.cyto.2019.154892_b0200","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010415","article-title":"VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: a cohort study","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"issue":"Supplement","key":"10.1016\/j.cyto.2019.154892_b0205","doi-asserted-by":"crossref","first-page":"S480","DOI":"10.4103\/0973-1482.194346","article-title":"Imbalance of T-helper 1\/T-helper 2 cytokines and impaired glucose tolerance among patient with acute coronary syndrome","volume":"14","author":"Zhao","year":"2018","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.cyto.2019.154892_b0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1741-7015-11-160","article-title":"Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial","volume":"11","author":"Zhao","year":"2013","journal-title":"BMC Med."},{"issue":"Suppl. 2","key":"10.1016\/j.cyto.2019.154892_b0215","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","article-title":"Interleukin-6 and diabetes: the good, the bad, or the indifferent?","volume":"54","author":"Kristiansen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2019.154892_b0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2018.02.103","article-title":"The potential pathogenic role of IL-17\/Th17 cells in both type 1 and type 2 diabetes mellitus","volume":"101","author":"Abdel-Moneim","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacotherapie"},{"issue":"9","key":"10.1016\/j.cyto.2019.154892_b0225","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc10-2274","article-title":"Type 1 diabetes and interferon therapy: a nationwide survey in Japan","volume":"34","author":"Nakamura","year":"2011","journal-title":"Diabetes care"},{"issue":"9","key":"10.1016\/j.cyto.2019.154892_b0230","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"10","key":"10.1016\/j.cyto.2019.154892_b0235","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/emmm.201201272","article-title":"A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation","volume":"4","author":"Cheng","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.cyto.2019.154892_b0240","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.4049\/jimmunol.1004133","article-title":"Attenuated atherosclerotic lesions in apoE-Fcgamma-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells","volume":"187","author":"Ng","year":"2011","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"13","key":"10.1016\/j.cyto.2019.154892_b0245","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1073\/pnas.1215840110","article-title":"B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile","volume":"110","author":"DeFuria","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI64941","article-title":"Direct control of hepatic glucose production by interleukin-13 in mice","volume":"123","author":"Stanya","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.cyto.2019.154892_b0255","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db15-1350","article-title":"Interleukin-13 pathway alterations impair invariant natural killer T-cell-mediated regulation of effector T cells in type 1 diabetes","volume":"65","author":"Usero","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2019.154892_b0260","doi-asserted-by":"crossref","first-page":"7209872","DOI":"10.1155\/2018\/7209872","article-title":"Serum levels of interleukin-13 increase in subjects with insulin resistance but do not correlate with markers of low-grade systemic inflammation","volume":"2018","author":"Martinez-Reyes","year":"2018","journal-title":"J. Diabetes Res."},{"issue":"8","key":"10.1016\/j.cyto.2019.154892_b0265","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.celrep.2017.01.076","article-title":"ER stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity","volume":"18","author":"Suzuki","year":"2017","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.cyto.2019.154892_b0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"Type 2 diabetes and quality of life","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010023","article-title":"Inflammation and oxidative stress in an obese state and the protective effects of gallic acid","volume":"11","author":"Dludla","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.cyto.2019.154892_b0280","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","article-title":"Inflammatory response in the CNS: friend or foe?","volume":"54","author":"Sochocka","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cyto.2019.154892_b0285","doi-asserted-by":"crossref","first-page":"976810","DOI":"10.1155\/2013\/976810","article-title":"Analysis of inflammatory mediators in type 2 diabetes patients","volume":"2013","author":"Al-Shukaili","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154892_b0290","article-title":"Aspalathin protects the heart against hyperglycemia-induced oxidative damage by up-regulating Nrf2 expression","volume":"22","author":"Dludla","year":"2017","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/j.cyto.2019.154892_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122772","article-title":"Nrf2, the master regulator of anti-oxidative responses","volume":"18","author":"Vomund","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2019.154892_b0300","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.12659\/MSM.908699","article-title":"Lutein suppresses oxidative stress and inflammation by Nrf2 activation in an osteoporosis rat model","volume":"24","author":"Li","year":"2018","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.cyto.2019.154892_b0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","article-title":"Mechanisms of inflammatory responses in obese adipose tissue","volume":"32","author":"Sun","year":"2012","journal-title":"Ann. Rev. Nutr."},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0310","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","article-title":"Inflammation and type 2 diabetes","volume":"38","author":"Calle","year":"2012","journal-title":"Diabetes Metabol."},{"key":"10.1016\/j.cyto.2019.154892_b0315","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/349710","article-title":"Exercise in the metabolic syndrome","volume":"2012","author":"Golbidi","year":"2012","journal-title":"Oxidat. Med. Cell. Longevity"},{"issue":"3","key":"10.1016\/j.cyto.2019.154892_b0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1900\/RDS.2006.3.118","article-title":"Diet, exercise and the metabolic syndrome","volume":"3","author":"Pitsavos","year":"2006","journal-title":"Rev. Diabetic Stud.: RDS"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619303217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619303217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:55Z","timestamp":1760907355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619303217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":64,"alternative-id":["S1043466619303217"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154892","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on the functional role of Th1\/Th2 cytokines in type 2 diabetes and related metabolic complications","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154892"}}